Pioglitazone after Ischemic Stroke or Transient Ischemic Attack

Kernan, Walter N., Viscoli, Catherine M., Furie, Karen L., Young, Lawrence H., Inzucchi, Silvio E., Gorman, Mark, Guarino, Peter D., Lovejoy, Anne M. +19 more·2016·New England Journal of Medicine

DOI 10.1056/nejmoa1506930

Cited by (1,110)

Items 501–600 of 1,110

Potential New Horizons for the Prevention of Cerebrovascular Diseases and Dementia
Leonardo Pantoni · 2019 · JAMA Neurology
Effects of Thiazolidinedione and New Antidiabetic Agents on Stroke
Chang Ho Ahn, Soo Kyung Lim · 2019 · Journal of Stroke
Trends in pioglitazone use among U.S. adults with type 2 diabetes and suspected nonalcoholic fatty liver disease
Phuc Le, Alexander M. Chaitoff, Michael B. Rothberg, Arthur J. McCullough, Naim Alkhouri · 2019 · Expert Opinion on Investigational Drugs
An overview of alogliptin + pioglitazone for the treatment of type 2 diabetes
Brian Tomlinson, Paul Chan, Christopher Wai Kei Lam · 2021 · Expert Opinion on Pharmacotherapy
Pioglitazone Has a Null Association with Inflammatory Bowel Disease in Patients with Type 2 Diabetes Mellitus
Chin‐Hsiao Tseng · 2022 · Pharmaceuticals
Therapeutic Targeting of Cellular Stress to Prevent Cardiovascular Disease: A Review of the Evidence
Arshag D. Mooradian · 2016 · American Journal of Cardiovascular Drugs
Management of Atherosclerotic Cardiovascular Disease Risk Factors in the Older Adult Patient With Diabetes
Mary T. Korytkowski, Daniel E. Forman · 2017 · Diabetes Care
Fracture shortly before stroke in mice leads to hippocampus inflammation and long-lasting memory dysfunction
Zhengxi Li, Meng Wei, Haiyan Lyu · 2019 · Journal of Cerebral Blood Flow & Metabolism
Antihyperglykämische Therapie bei Diabetes mellitus Typ 2 (Update 2019)
Martin Clodi, Heidemarie Abrahamian, Felix Aberer, Alexander Bräuer, Kadriye Aydinkoc-Tuzcu, Helmut Brath, Johanna Maria Brix, Heinz Drexel, Peter Fasching, Astrid Feder et al. · 2019 · Wiener klinische Wochenschrift
Sodium-Glucose Cotransporter-2 Inhibitors and Protection Against stroke in Patients with type 2 Diabetes and Impaired Renal Function: A Systematic Review and Meta-Analysis
Fotios Barkas, Sempastian Filippas-Ntekouan, Evangelos N. Liberopoulos, Theodosios D. Filippatos, Haralampos J. Milionis · 2021 · Journal of Stroke and Cerebrovascular Diseases
Clinical implications of fracture severity risk with pioglitazone: a systematic review and meta-analysis of clinical randomized trials
Hala F. Azhari, Jesse Dawson · 2025 · Frontiers in Pharmacology
Downhill hiking improves low-grade inflammation, triglycerides, body weight and glucose tolerance
Heinz Drexel, ARTHUR MADER, Christoph H. Saely, Gerda Tautermann, Jörn Fredrik Dopheide, Alexander Vonbank · 2021 · Scientific Reports
Glucolipid metabolism improvement in impaired glucose tolerance subjects consuming a Quinoa-based diet: a randomized parallel clinical trial
Hongli Zeng, Xiangsheng Cai, Zhenyang Qiu, Yuchan Liang, Lu Huang · 2023 · Frontiers in Physiology
Insulin sensitizers in 2023: lessons learned and new avenues for investigation
Jerry R. Colca, Steven P. Tanis, Rolf F. Kletzien, Brian N. Finck · 2023 · Expert Opinion on Investigational Drugs
Disability and Recurrent Stroke Among Participants in Stroke Prevention Trials
Adam de Havenon, Catherine M. Viscoli, Dawn Kleindorfer, Heidi J. Sucharew, Alen Delic, Christopher J. Becker, David Robinson, Shadi R. Yaghi, Vivian Li, Maarten G. Lansberg et al. · 2024 · JAMA Network Open
Evaluation of exposure to pioglitazone and risk of prostate cancer: a nested case–control study
Naomi Boxall, Dimitri Bennett, Matthias Hünger · 2016 · BMJ Open Diabetes Research & Care
Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis
Fernando Bril, Kenneth J. Cusi · 2017 · Annals of Internal Medicine
Cardiovascular Effects of Pioglitazone or Sulfonylureas According to Pretreatment Risk: Moving Toward Personalized Care
Olga Vaccaro, Giuseppe Lucisano, Maria Masulli, Enzo Bonora, Stefano Del Prato, Angela Albarosa Rivellese, Carlo Bruno Giorda, Paolo Mocarelli, Sebastiano Squatrito, Aldo Pietro Maggioni et al. · 2019 · The Journal of Clinical Endocrinology & Metabolism
Association between normal triglyceride and insulin resistance in US adults without other risk factors: a cross-sectional study from the US National Health and Nutrition Examination Survey, 2007–2014
Chunli Bi, Lijuan Wang, Chong Sun, Mengzi Sun, Pingping Zheng, Zhiqiang Xue, Li Shen, Pan Pan, Jiagen Li, Yaogai Lv et al. · 2019 · BMJ Open
Medical Management for Secondary Stroke Prevention
Anthony S. Kim · 2020 · CONTINUUM Lifelong Learning in Neurology
Novel and emerging therapies in pulmonary arterial hypertension
Steven J. Cassady, Danielle Soldin, Gautam V. Ramani · 2022 · Frontiers in Drug Discovery
Impact of Metabolic Activity of Vertebra and Amygdala on Stroke Recurrence: A Prospective Cohort Study
Jeong‐Min Kim, Reeree Lee, Yongsung Kim, Hae-Bong Jeong, Eun Seong Lee, Hye Ryoun Kim, Kwang‐Yeol Park, Ju Won Seok · 2023 · Circulation Cardiovascular Imaging
Diabetes medications and cardiovascular disease: at long last progress
Beatrice C. Lupsa, Silvio E. Inzucchi · 2018 · Current Opinion in Endocrinology Diabetes and Obesity
Effect of Pioglitazone in Combination with Moderate Dose Statin on Atherosclerotic Inflammation: Randomized Controlled Clinical Trial Using Serial FDG-PET/CT
Eun Ho Choo, Eun Ji Han, Chan Joon Kim, Sung-Hoon Kim, Joo Hyun O, Kiyuk Chang, Ki Bae Seung · 2018 · Korean Circulation Journal
Clinician's Guide to the Updated ABCs of Cardiovascular Disease Prevention: A Review Part 2
Kelly E Arps, Vincent A. Pallazola, Rhanderson N. Cardoso, Joseph Meyer, Richard Jones, Jacqueline M. Latina, Ty J. Gluckman, Neil J. Stone, Roger Scott Blumenthal, John William McEvoy · 2019 · The American Journal of Medicine
Pharmacologic Randomized Clinical Trials in Prevention of Type 2 Diabetes
William C. Knowler, Jill P. Crandall · 2019 · Current Diabetes Reports
Pioglitazone for primary stroke prevention in Asian patients with type 2 diabetes and cardiovascular risk factors: a retrospective study
Yi‐Chih Hung, Lu‐Ting Chiu, Hung‐Yu Huang, Da‐Tian Bau · 2020 · Cardiovascular Diabetology
Comparison of oral glucose tolerance test and HbA1c in detection of disorders of glucose metabolism in patients with acute stroke
Karl Matz, Jaakko O. Tuomilehto, Yvonne Teuschl, Alexandra Dachenhausen, Michael Brainin · 2020 · Cardiovascular Diabetology
Post-Treatment with Amorfrutin B Evokes PPARγ-Mediated Neuroprotection against Hypoxia and Ischemia
Agnieszka Wnuk, Karolina Przepiórska, Bernadeta Angelika Pietrzak, Małgorzata Kajta · 2021 · Biomedicines
Treatment with MQA, a Derivative of Caffeoylquinic Acid, Provides Neuroprotective Effects against Cerebral Ischemia Through Suppression of the p38 Pathway and Oxidative Stress in Rats
Long Chen, Dan‐Ni Liu, Yu Wang · 2019 · Journal of Molecular Neuroscience
Mitogen-Activated Protein Kinase and Nuclear Hormone Receptor Crosstalk in Cancer Immunotherapy
Elke Burgermeister · 2023 · International Journal of Molecular Sciences
Combination chemotherapy against colorectal cancer cells: Co-delivery of capecitabine and pioglitazone hydrochloride by polycaprolactone-polyethylene glycol carriers
Fahima Danesh Pouya, Roya Salehi, Yousef Rasmi, Fatemeh Kheradmand, Anahita Fathi Azarbayjani · 2023 · Life Sciences
Pioglitazone Protects Tubular Epithelial Cells during Kidney Fibrosis by Attenuating miRNA Dysregulation and Autophagy Dysfunction Induced by TGF-β
Anna Manzéger, Gantsetseg Garmaa, Miklos M Mozes, Georg Hansmann, Gábor Kökény · 2023 · International Journal of Molecular Sciences
Cardio‐renal‐metabolic disease in primary care setting
Mahmoud Ashraf Ibrahim, Ebtesam M. Ba-Essa, Jason C. Baker, Avivit Cahn, Antonio Ceriello, Francesco Cosentino, Melanie Jane Davies, Robert H. Eckel, Luc Van Gaal, Peter Gæde et al. · 2023 · Diabetes/Metabolism Research and Reviews
Ethnic Disparities in the Risk Factors, Morbidity, and Mortality of Cardiovascular Disease in People With Diabetes
Lekshmi Nair, Peace Asuzu, Samuel E. Dagogo-Jack · 2024 · Journal of the Endocrine Society
Antidiabetic agents and cardiovascular outcomes in patients with heart diseases
Judy W. M. Cheng, Hisham A. Badreldin, Dhiren K Patel, Snehal H. Bhatt · 2017 · Current Medical Research and Opinion
Metabolic syndrome identifies normal weight insulin-resistant stroke patients at risk for recurrent vascular disease
Jennifer L. Dearborn, Catherine M. Viscoli, Silvio E. Inzucchi, Lawrence H. Young, Walter N. Kernan · 2018 · International Journal of Stroke
Pioglitazone: inexpensive; very effective at reducing HbA1c; no evidence of bladder cancer risk; plenty of evidence of cardiovascular benefit
Robert E. J. Ryder, Ralph A. DeFronzo · 2019 · Diabetic Medicine
Cardiovascular Safety and Benefits of Noninsulin Antihyperglycemic Drugs for the Treatment of Type 2 Diabetes Mellitus—Part 1
Srikanth Yandrapalli, George P. Jolly, Adam M. Horblitt, Gayatri Pemmasani, Abdallah Sanaani, Wilbert S. Aronow, William H. Frishman · 2020 · Cardiology in Review
Nonalcoholic Fatty Liver Disease and Implications for Older Adults with Diabetes
Alessandro Mantovani, Giovanni Targher, Giacomo Zoppini · 2020 · Clinics in Geriatric Medicine
Tackling cardiometabolic risk in the Asia Pacific region
Jian‐Jun Li, Khung Keong Yeo, Kathyrn Tan, Junya Ako, Rungroj Krittayaphong, Ru‐San Tan, Philip E. Aylward, Carolyn Su Ping Lam, Sang Hong Baek, Jamshed J Dalal et al. · 2020 · American Journal of Preventive Cardiology
Pioglitazone use associated with reduced risk of the first attack of ischemic stroke in patients with newly onset type 2 diabetes: a nationwide nested case–control study
Jung-Hee Ha, Dong‐Woo Choi, Keun You Kim, Chung Mo Nam, Eosu Kim · 2021 · Cardiovascular Diabetology
Comparative Effects of Sodium-Glucose Cotransporter 2 Inhibitor and Thiazolidinedione Treatment on Risk of Stroke among Patients with Type 2 Diabetes Mellitus
Seung Eun Lee, Hyewon Nam, Han Seok Choi, Hoseob Kim, Dae‐Sung Kyoung, Kyoung‐Ah Kim · 2022 · Diabetes & Metabolism Journal
Effective Utilization of Oral Hypoglycemic Agents to Achieve Individualized HbA1c Targets in Patients with Type 2 Diabetes Mellitus
Margaret Bannister, Jenny Berlanga · 2016 · Diabetes Therapy
Low dose prednisolone and insulin sensitivity differentially affect arterial stiffness and endothelial function: An open interventional and cross-sectional study
Carolyn J. Petersons, Brenda L. Mangelsdorf, Anne Poljak, Malcolm Smith, Jerry Richard Greenfield, Campbell Henry Thompson, Morton G. Burt · 2017 · Atherosclerosis
Effects of Lobeglitazone, a New Thiazolidinedione, on Osteoblastogenesis and Bone Mineral Density in Mice
Kyoung Min Kim, Hyun-Jin Jin, Seo Yeon Lee · 2017 · Endocrinology and Metabolism
The influence of anti-hyperglycemic drug therapy on cardiovascular and heart failure outcomes in patients with type 2 diabetes mellitus
Rabea Asleh, Mohammad Sheikh‐Ahmad, Αlexandros Briasoulis, Sudhir S. Kushwaha · 2017 · Heart Failure Reviews
Study design choices for evaluating the comparative safety of diabetes medications: An evaluation of pioglitazone use and risk of bladder cancer in older US adults with type‐2 diabetes
Elizabeth M. Garry, John B. Buse, Mugdha Gokhale, Jennifer Leigh Lund, Matthew E. Nielsen, Virginia Pate, Til Stürmer‎ · 2019 · Diabetes Obesity and Metabolism
Long-Term Risk of Hip Fracture After Ischemic Stroke
Setareh Salehi Omran, Santosh B. Murthy, Babak Benjamin Navi, Alexander Eliot Merkler · 2019 · The Neurohospitalist
Type 2 diabetes mellitus and cardiovascular risk; what the pharmacotherapy can change through the epigenetics
Pavlina A. Andreeva-Gateva, Ivelina Mihaleva, Ivanka Istalianova Dimova · 2019 · Postgraduate Medicine
Factors Influencing 1-Year Medication Adherence of Korean Ischemic Stroke Survivors
Gye-Gyoung Kim, Duckhee Chae, Man‐Seok Park, Sung‐Hee Yoo · 2020 · International Journal of Behavioral Medicine
Medical treatment of type 2 diabetes mellitus: Recommendations of the Diabetes, Obesity and Nutrition Group of the Spanish Society of Internal Medicine
Francisco Javier Carrasco-Sánchez, José María Fernández Rodríguez, Javier Ena, Ricardo Gómez‐Huelgas, Juana Carretero‐Gómez · 2020 · Revista Clínica Española (English Edition)
Peroxisome proliferator-activated receptor gamma agonists for preventing recurrent stroke and other vascular events in people with stroke or transient ischaemic attack
Jia Liu, Lu‐Ning Wang · 2023 · Cochrane Database of Systematic Reviews
Cardiovascular Safety of Antihyperglycemic Agents: “Do Good or Do No Harm”
Antonis S. Manolis, Theodora A. Manolis, Antonis S. Manolis · 2018 · Drugs
Triglyceride-glucose index and non-culprit coronary plaque characteristics assessed by optical coherence tomography in patients following acute coronary syndrome: A cross-sectional study
Zi-Wei Zhao, Chi Liu, Qi Zhao, Ying-Kai Xu, Yujing Cheng, Tienan Sun, Yujie Zhou · 2022 · Frontiers in Cardiovascular Medicine
Anti‐obesity effects exerted by Dioscorea opposita Thunb. polysaccharides in diet‐induced obese mice
Shengnan Li, Dian‐Long Zhang, Zhenhui Wang, Wen‐Ting Song, Wenbo Chen, Ge‐Li Hu, Lu‐Ying Han, Jing‐Chun Zhou · 2023 · Food Science & Nutrition
Pre-Prediabetes: Insulin Resistance Is Associated With Cardiometabolic Risk in Nonobese Patients (STOP DIABETES)
John Armato, Ralph Anthony DeFronzo, Muhammad A Abdul‐Ghani, Ron Ruby · 2024 · The Journal of Clinical Endocrinology & Metabolism
Pleiotropic Effects of Peroxisome Proliferator-Activated Receptor Alpha and Gamma Agonists on Myocardial Damage: Molecular Mechanisms and Clinical Evidence—A Narrative Review
María Esther Rubio-Ruiz, Juan Carlos Plata-Corona, Elizabeth Soria‐Castro, Julieta Anabell Díaz-Juárez, María Sánchez-Aguilar · 2024 · Cells
Leveraging Mendelian randomization to inform drug discovery and development for ischemic stroke
Iyas Daghlas, Dipender Gill · 2024 · Journal of Cerebral Blood Flow & Metabolism
Diagnosis and management of type 2 diabetes mellitus in patients with ischaemic heart disease and acute coronary syndromes - a review of evidence and recommendations
Muhammad Usman Shah, Alun Roebuck, Bala Srinivasan, Joanna Kate Ward, Paul Edward Squires, Claire Elizabeth Hills, Kelvin Lee · 2025 · Frontiers in Endocrinology
Tratamiento médico de la diabetes mellitus tipo 2: recomendaciones del Grupo de Diabetes, Obesidad y Nutrición de la Sociedad Española de Medicina Interna
Francisco Javier Carrasco-Sánchez, José María Fernández Rodríguez, Javier Ena, Ricardo Gómez‐Huelgas, Juana Carretero‐Gómez · 2020 · Revista Clínica Española
Anti-inflammatory and anti-proliferative action of adiponectin mediated by insulin signaling cascade in human vascular smooth muscle cells
Eugênio Cersósimo, Xiaojing Xu, Tomoko Terasawa, Lily Dong · 2020 · Molecular Biology Reports
Cardiovascular Outcome Trials with Glucose-Lowering Drugs
Tina Kaur Thethi, Anika Bilal, Richard E. Pratley · 2021 · Current Cardiology Reports
Following the LEADER – why this and other recent trials signal a major paradigm shift in the management of type 2 diabetes
Mikhail Kosiborod · 2016 · Journal of Diabetes and its Complications
Historique des études cardiovasculaires : de l’UGDP… aux dernières études
André Jacques Scheen · 2017 · Médecine des Maladies Métaboliques
Effects of pioglitazone on cognitive function in patients with a recent ischaemic stroke or TIA: a report from the IRIS trial
Karen L. Furie, Catherine M. Viscoli, Mark Gorman, Gary A. Ford, Lawrence H. Young, Silvio E. Inzucchi, Peter Guarino, Anne M. Lovejoy, ROBIN A. CONWIT, David Tanné et al. · 2017 · Journal of Neurology Neurosurgery & Psychiatry
Recent advances in the management of transient ischemic attacks
Camilo R. Gomez, Michael J. Schneck, José Biller · 2017 · F1000Research
Effect of pioglitazone on cardiometabolic profiles and safety in patients with type 2 diabetes undergoing percutaneous coronary artery intervention: a prospective, multicenter, randomized trial
On behalf of the Pioglitazone Reduce Inflammation and Restenosis with and without Drug Eluting Stent (PRIDE) Study Investigators, Atsushi Tanaka, Sho Komukai, Yoshisato Shibata, Hiroyoshi Yokoi, Yoshihiro Iwasaki, Tomohiro Kawasaki, Kenji Horiuchi, Kōichi Nakao, Takafumi Ueno et al. · 2018 · Heart and Vessels
Distance from Home to Research Center: A Barrier to In-Person Visits but Not Treatment Adherence in a Stroke Trial
Enrique C. C Leira, Catherine M. Viscoli, Linnea A. Polgreen, Mark Gorman, Walter N. Kernan, <collab>on behalf of the IRIS Trial Investigators</collab> · 2018 · Neuroepidemiology
The past decade in type 2 diabetes and future challenges
JIHAD A. HADDAD, Aiman N. Haddad · 2018 · HORMONES
Achievement of Guideline-Recommended Weight Loss Among Patients With Ischemic Stroke and Obesity
Jennifer L. Dearborn, Catherine M. Viscoli, Lawrence H. Young, Mark Gorman, Karen L. Furie, Walter N. Kernan · 2019 · Stroke
Role of peroxisome proliferator‐activated receptors in stroke prevention and therapy—The best is yet to come?
Marcin Gamdzyk, Cameron Lenahan, Jiping Tang, John H. Zhang · 2020 · Journal of Neuroscience Research
Nonalcoholic Fatty Liver Disease (NAFLD) for Primary Care Providers: Beyond the Liver
Eddison Godinez Leiva, Fernando Bril · 2020 · Current Hypertension Reviews
Pioglitazone, Bladder Cancer, and the Presumption of Innocence
Georgios S. Papaetis · 2022 · Current Drug Safety
Time-to-event methodology improved statistical evaluation in register-based health services research
Tobias Bluhmki, Peter Bramlage, Michael Volk, Matthias Kaltheuner, Thomas Danne, Wolfgang Rathmann, Jan Beyersmann · 2016 · Journal of Clinical Epidemiology
PPARγ Agonist Pioglitazone Prevents Hypoxia-induced Cardiac Dysfunction by Reprogramming Glucose Metabolism
Yijin Wang, Ru Zhang, Qian Chen, Zhangwen Lei, Caiyu Shi, Yifei Pang, Shan'an Zhang, Linjie He, Longtao Xu, Jinliang Xing et al. · 2024 · International Journal of Biological Sciences
Synergistic effects of glucose tolerance and BMI on cardiovascular events and all-cause mortality in a healthy population: CA.ME.LI.A study 7 years follow-up
B. Monica, Elena Bianco, Lucia Centofanti, Antonio Giampiero Russo, Michele Dei, Paola Zermiani, Camillo Morano, Federica Samartin, Emanuela Bertolini, Francesco Bifari et al. · 2024 · American Journal of Physiology-Endocrinology and Metabolism
Risk factors for bone fractures in type 2 diabetes and the impact of once-weekly exenatide: insights from an EXSCEL post-hoc analysis
Ernesto Maddaloni, Ruth L. Coleman, Rury R. Holman · 2025 · Diabetes Research and Clinical Practice
TyG-BMI and TyG/BMI %: valuable evaluation tools for predicting unfavorable prognosis in ischemic stroke patients with large vessel occlusion after endovascular therapy
Jianru Li, Shandong Jiang, Peizheng Guo, Weibo lin, Jun Yu, Liang Xu, Xu Li, Xianyi Chen, Bin Fang, Cong Qian et al. · 2025 · Journal of Stroke and Cerebrovascular Diseases
A review on cardiovascular effects of newer hypoglycaemic medications
B. Tate Cutshall, Jennifer D. Twilla, Andrew S. Olinger, Carrie S. Oliphant · 2017 · Annals of Medicine
Associations of low-carbohydrate and low-fat intakes with all-cause mortality in subjects with prediabetes with and without insulin resistance
Chia-Lin Lee, Wei-Ju Liu, Jun‐Sing Wang · 2020 · Clinical Nutrition
Nonleisure-Time Physical Activity Guidance Following Minor Ischemic Stroke: A Randomized Clinical Trial
Ryota Ashizawa, Kazuma YAMASHITA, Koki Take, Kengo OKAWARA, Eri Mochizuki, Asuka Sakamoto, Yoshinobu Yoshimoto · 2021 · Adapted Physical Activity Quarterly
Neurotoxicity of Unconjugated Bilirubin in Neonatal Hypoxic-Ischemic Brain Injury in vitro
Carlo Dani, Simone Pratesi, Guido Mannaioni, Elisabetta Gerace · 2021 · Frontiers in Pediatrics
Association Between Insulin Resistance and Remote Diffusion-Weighted Imaging Lesions in Primary Intracerebral Hemorrhage
Xianghua Ye, Jianli Zhang, Yu-jia Jin, Dan Shen, Xiaodi Hao, Jiawen Li, Jiawei Zhong, Luhang Jin, Lusha Tong, Feng Gao · 2021 · Frontiers in Immunology
Thiazolidinedione Use in Individuals With Type 2 Diabetes and Chronic Obstructive Pulmonary Disease
Fu‐Shun Yen, James Cheng‐Chung Wei, Yu‐Cih Yang, Chih‐Cheng Hsu, Chii‐Min Hwu · 2021 · Frontiers in Medicine
Glucose-Lowering and the Risk of Cardiovascular Events With Antidiabetic Therapies: A Systematic Review and Additive-Effects Network Meta-Analysis
Luiz Sérgio Fernandes de Carvalho, Ana Cláudia Cavalcante Nogueira, Isabella Bonilha, Beatriz Luchiari, Alexander Koglin Benchimol, Carlos Eduardo Barra Couri, Jairo Lins Borges, Joaquim Barreto, Andrei Carvalho Sposito · 2022 · Frontiers in Cardiovascular Medicine
Oldies but Goodies: Thiazolidinedione as an Insulin Sensitizer with Cardioprotection
Eun-Hee Cho · 2022 · Diabetes & Metabolism Journal
Novel Approaches to the Management of Diabetes Mellitus in Patients with Coronary Artery Disease
Evangelos K. Oikonomou, Maria Xenou, George Ε. Zakynthinos, Paraskevas Tsaplaris, Stamatios Lampsas, Evanthia Bletsa, Ioannis Gialamas, Konstantinos I. Kalogeras, Athina Goliopoulou, Maria Ioanna Gounaridi et al. · 2023 · Current Pharmaceutical Design
Empagliflozin improves insulin sensitivity in patients with recent acute coronary syndrome and newly detected dysglycaemia
Elena Fortin, Magnus Lundin, Linda Mellbin, Anna Norhammar, Per Näsman, Stina Smetana, Peder Sörensson, Ele Ferrannini, Lars Rydén, Giulia Ferrannini · 2023 · Cardiovascular Diabetology
Diabetes mellitus and heart disease
Preethi Chandrasekaran, Ralf Weiskirchen · 2024 · Metabolism and Target Organ Damage
Unexplained Residual Risk In Type 2 Diabetes: How Big Is The Problem?
Sivaram Neppala, Jemema Rajan, Eric Yang, Ralph A. DeFronzo · 2024 · Current Cardiology Reports
Long-term effects of pioglitazone on first attack of ischemic cerebrovascular disease in older people with type 2 diabetes
Shih‐Wei Lai, Hsien-Feng Lin, Cheng‐Li Lin · 2016 · Medicine
The Transcription Factor IRF6 Co-Represses PPARγ-Mediated Cytoprotection in Ischemic Cerebrovascular Endothelial Cells
Rongzhong Huang, Zicheng Hu, Yuxing Feng, Lehua Yu, Xingsheng Li · 2017 · Scientific Reports
The effect of antidiabetic medications on the cardiovascular system: a critical appraisal of current data
Panagiotis G. Anagnostis, Pavlos Siolos, Konstantinos Christou, Nifon K. Gkekas, Nikoletta Kosmidou, Vasilios Gabriel Athyros, Asterios I. Karagiannis · 2018 · HORMONES
Pioglitazone Prevents Hemorrhagic Infarction After Transient Focal Ischemia in Type 2 Diabetes
Hiroshi Hasegawa, Kenji Yatomi, Yumiko Mitome-Mishima, Nobukazu Miyamoto, Ryota Tanaka, Hidenori Oishi, Hajime Arai, Nobutaka Hattori, Takao Urabe · 2020 · Neuroscience Research
Measures of Insulin Resistance as a Screening Tool for Dysglycemia in Patients With Coronary Artery Disease: A Report From the EUROASPIRE V Population
Giulia Ferrannini, Dirk De Bacquer, Iris Erlund, Viveca Gyberg, Kornelia Kotseva, Linda Mellbin, Anna Norhammar, Oliver Schnell, Jaakko O. Tuomilehto, Terhi Vihervaara et al. · 2022 · Diabetes Care
Xanthine oxidase inhibition and white matter hyperintensity progression following ischaemic stroke and transient ischaemic attack (XILO-FIST): a multicentre, double-blinded, randomised, placebo-controlled trial
Jesse Dawson, Michele Robertson, David Alexander Dickie, Philip M. Bath, Kirsten P. N. Forbes, Terence J. Quinn, Niall M. Broomfield, Krishna Dani, Alex S. F. Doney, J. Graeme Houston et al. · 2023 · EClinicalMedicine
Can Cardiovascular Epidemiology and Clinical Trials Close the Risk Management Gap Between Diabetes and Prediabetes?
Leigh Perreault, Kristine Færch, Edward W. Gregg · 2017 · Current Diabetes Reports
Rosiglitazone lowers resting and blood pressure response to exercise in men with type 2 diabetes: A 1‐year randomized study
Marie‐Ève Piché, Anne‐Sophie Laberge, Patrice Brassard, Benoît J. Arsenault, Olivier Francois Bertrand, Jean‐Pierre Després, Olivier Costerousse, Paul Poirier · 2018 · Diabetes Obesity and Metabolism
Glucose-lowering treatment in cardiovascular and peripheral artery disease
Rosa Suades, Francesco Cosentino, Lina Badimón · 2018 · Current Opinion in Pharmacology